Evidence map›Paper›PMID 27830652›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Synthetic genome readers target clustered binding sites across diverse chromatin states.

Graham S Erwin, Matthew P Grieshop, Devesh Bhimsaria, Truman J Do, José A Rodríguez-Martínez, Charu Mehta, Kanika Khanna, Scott A Swanson, Ron Stewart, James A Thomson and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Specificity landscapes unmask submaximal binding site preferences of transcription factors.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Graham S ErwinDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.
Matthew P GrieshopDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.
Devesh BhimsariaDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.
Truman J DoDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.ORCID 0000-0002-4285-1773
José A Rodríguez-MartínezDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.
Charu MehtaDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.
Kanika KhannaDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.
Scott A SwansonMorgridge Institute for Research, Madison, WI 53715.
Ron StewartMorgridge Institute for Research, Madison, WI 53715.
James A ThomsonMorgridge Institute for Research, Madison, WI 53715.
Parameswaran RamanathanDepartment of Electrical and Computer Engineering, University of Wisconsin-Madison, Madison, WI 53706.
Aseem Z AnsariDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, azansari@wisc.edu.ORCID 0000-0003-1432-4498
University of Wisconsin–Madison · USMorgridge Institute for Research · US

Funding

GRADUATE TRAINING IN MOLECULAR BIOSCIENCEST32GM007215 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI HULL, CHRISTINA M · 1985 to 2018
$22.5M
Institutional Training in the Genomic SciencesT32HG002760 · NHGRI · UNIVERSITY OF WISCONSIN-MADISON · PI Qiongshi Lu · 2003 to 2026
$17.7M
INTEGRATED TRAINING FOR PHYSICIAN-SCIENTISTST32GM008692 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BURKARD, MARK E · 1998 to 2020
$10.3M
Midwest Progenitor Cell ConsortiumU01HL099773 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI THOMSON, JAMES ALEXANDER · 2009 to 2015
$7.8M
Integrated Training For Physician-ScientistsT32GM140935 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Anna Huttenlocher, Jeniel E Nett · 2021 to 2026
$6.5M
Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic moleculesR01CA133508 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI ANSARI, ASEEM Z · 2008 to 2012
$1.5M
NCI NIH HHS R01 CA133508NHGRI NIH HHS T32 HG002760NHLBI NIH HHS U01 HL099773NIGMS NIH HHS T32 GM007215NIGMS NIH HHS T32 GM008692NIGMS NIH HHS T32 GM140935
6 · The paper itself

Abstract

Targeting the genome with sequence-specific DNA-binding molecules is a major goal at the interface of chemistry, biology, and precision medicine. Polyamides, composed of N-methylpyrrole and N-methylimidazole monomers, are a class of synthetic molecules that can be rationally designed to "read" specific DNA sequences. However, the impact of different chromatin states on polyamide binding in live cells remains an unresolved question that impedes their deployment in vivo. Here, we use cross-linking of small molecules to isolate chromatin coupled to sequencing to map the binding of two bioactive and structurally distinct polyamides to genomes directly within live H1 human embryonic stem cells. This genome-wide view from live cells reveals that polyamide-based synthetic genome readers bind cognate sites that span a range of binding affinities. Polyamides can access cognate sites within repressive heterochromatin. The occupancy patterns suggest that polyamides could be harnessed to target loci within regions of the genome that are inaccessible to other DNA-targeting molecules.

Indexed as

Binding SitesCell LineChromatinCross-Linking ReagentsDNAGenome, HumanHuman Embryonic Stem CellsHumansNylonsSequence Analysis, DNASmall Molecule LibrariesChromatinCross-Linking ReagentsDNANylonsSmall Molecule Librarieschemical genomicsCOSMICgenome targetingmolecular recognitionpolyamide

Identifiers

PMID27830652
PMCPMC5127382
OpenAlexW2555285448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.